Literature DB >> 17478786

Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.

Miguel Martínez-Rodríguez1, David Ramos, Pilar Soriano, Manish Subramaniam, Samuel Navarro, Antonio Llombart-Bosch.   

Abstract

The differential diagnosis between carcinoma of the urinary bladder and adenocarcinoma of the prostate can be difficult, especially in the poorly differentiated forms infiltrating the neighboring organs. In this article, the authors report 2 cases that pose a diagnostic dilemma to the pathologist. The first is an infiltration of the bladder by a poorly differentiated adenocarcinoma of the prostate, which was clinically suspected as a papillary urothelial neoplasm. The second is a collision tumor composed of prostatic adenocarcinoma and urothelial carcinoma observed on a core needle biopsy of the prostate. In both cases, a large panel of immunohistochemical markers were used and demonstrated positivity for prostate-specific antigen and alpha methyl racemase in the prostatic carcinomas and immunoreactivity for CK7, CK20, Ag 34betaE12, and p53 in the urothelial carcinoma. The differentiating histological and immunohistochemical findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478786     DOI: 10.1177/1066896906295822

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

1.  Cancer of unknown primary finally revealed to be a metastatic prostate cancer: a case report.

Authors:  Jung Yeon Cho; Eun Jin Shim; In Seon Kim; Eun Mi Nam; Moon Young Choi; Kyung Eun Lee; Yeung Chul Mun; Chu Myoung Seoung; Soon Nam Lee; Dong Eun Song; Woon Sup Han
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

2.  A novel subtype of primary prostatic adenocarcinoma: A case report.

Authors:  Xiaoqing Yang; Chen Xu; Jianing Guo; Chunrui Yang; Yuming Yang; Ruifa Han
Journal:  Oncol Lett       Date:  2013-09-02       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.